US Stock MarketDetailed Quotes

ANEB Anebulo Pharmaceuticals

Watchlist

1.826
0.0000.00%

Close Aug 28 15:58 ET

47.36MMarket Cap-4935P/E (TTM)

Anebulo Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Mar 31, 2024

(Q2)Dec 31, 2023

(Q1)Sep 30, 2023

(FY)Jun 30, 2023

(Q4)Jun 30, 2023

(Q3)Mar 31, 2023

(Q2)Dec 31, 2022

(Q1)Sep 30, 2022

(FY)Jun 30, 2022

(Q4)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

31.64%-1.5M

30.49%-1.81M

-34.07%-2.73M

-78.09%-9.68M

-42.52%-2.85M

-49.91%-2.19M

-117.68%-2.61M

-161.46%-2.03M

-11.62%-5.44M

42.83%-2M

Net income from continuing operations

40.90%-1.65M

28.99%-2.72M

5.02%-2.48M

-71.89%-11.73M

-7.44%-2.5M

-49.11%-2.8M

-256.66%-3.83M

-68.14%-2.61M

77.44%-6.83M

92.02%-2.32M

Other non cash items

--59.7K

----

Change In working capital

-114.38%-55.17K

-34.21%652.56K

-224.80%-456.8K

28.28%1.16M

-697.96%-577.23K

32.35%383.79K

550.78%991.91K

-50.63%366.01K

162.81%907.78K

108.56%96.53K

-Change in prepaid assets

-119.59%-51.94K

417.10%355.57K

-124.36%-104.56K

-4.50%608.21K

53.08%-154.95K

4.31%265.11K

-79.64%68.76K

14.40%429.29K

138.19%636.89K

69.32%-330.22K

-Change in payables and accrued expense

-102.73%-3.24K

-67.83%297K

-456.65%-352.24K

105.34%556.27K

-198.95%-422.28K

231.21%118.68K

265.51%923.15K

-117.29%-63.28K

23.67%270.9K

928.12%426.75K

Cash from discontinued investing activities

Operating cash flow

31.64%-1.5M

30.49%-1.81M

-34.07%-2.73M

-78.09%-9.68M

-42.52%-2.85M

-49.91%-2.19M

-117.68%-2.61M

-161.46%-2.03M

-11.62%-5.44M

42.83%-2M

Investing cash flow

Cash flow from continuing investing activities

Cash from discontinued investing activities

Financing cash flow

Cash flow from continuing financing activities

74.95%-62.35K

6.38M

-68.16K

-248.93K

6.7M

Net common stock issuance

--0

--6.65M

--0

--6.65M

--0

Proceeds from stock option exercised by employees

--0

--52.4K

--0

--52.4K

--0

Net other financing activities

--0

----

---317.08K

---68.16K

--0

----

Cash from discontinued financing activities

Financing cash flow

--0

74.95%-62.35K

--0

--6.38M

---68.16K

--0

---248.93K

--6.7M

--0

Net cash flow

Beginning cash position

-59.37%6.64M

-55.65%8.52M

-22.69%11.25M

-27.21%14.55M

-14.40%14.16M

-9.18%16.36M

0.03%19.21M

-27.21%14.55M

560.69%19.99M

400.37%16.55M

Current changes in cash

31.64%-1.5M

34.37%-1.88M

-158.45%-2.73M

39.29%-3.3M

-45.92%-2.92M

-49.91%-2.19M

-138.44%-2.86M

699.72%4.67M

-132.06%-5.44M

-111.99%-2M

End cash Position

-63.66%5.15M

-59.37%6.64M

-55.65%8.52M

-22.69%11.25M

-14.40%14.16M

-9.18%16.36M

0.03%19.21M

-27.21%14.55M

Free cash flow

31.64%-1.5M

30.49%-1.81M

-34.07%-2.73M

-78.09%-9.68M

-42.52%-2.85M

-49.91%-2.19M

-117.68%-2.61M

-161.46%-2.03M

-11.62%-5.44M

42.83%-2M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Mar 31, 2024	(Q2)Dec 31, 2023	(Q1)Sep 30, 2023	(FY)Jun 30, 2023	(Q4)Jun 30, 2023	(Q3)Mar 31, 2023	(Q2)Dec 31, 2022	(Q1)Sep 30, 2022	(FY)Jun 30, 2022	(Q4)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	31.64%-1.5M	30.49%-1.81M	-34.07%-2.73M	-78.09%-9.68M	-42.52%-2.85M	-49.91%-2.19M	-117.68%-2.61M	-161.46%-2.03M	-11.62%-5.44M	42.83%-2M
Net income from continuing operations	40.90%-1.65M	28.99%-2.72M	5.02%-2.48M	-71.89%-11.73M	-7.44%-2.5M	-49.11%-2.8M	-256.66%-3.83M	-68.14%-2.61M	77.44%-6.83M	92.02%-2.32M
Other non cash items	--59.7K	----	----	----	----	----	----	----	----	----
Change In working capital	-114.38%-55.17K	-34.21%652.56K	-224.80%-456.8K	28.28%1.16M	-697.96%-577.23K	32.35%383.79K	550.78%991.91K	-50.63%366.01K	162.81%907.78K	108.56%96.53K
-Change in prepaid assets	-119.59%-51.94K	417.10%355.57K	-124.36%-104.56K	-4.50%608.21K	53.08%-154.95K	4.31%265.11K	-79.64%68.76K	14.40%429.29K	138.19%636.89K	69.32%-330.22K
-Change in payables and accrued expense	-102.73%-3.24K	-67.83%297K	-456.65%-352.24K	105.34%556.27K	-198.95%-422.28K	231.21%118.68K	265.51%923.15K	-117.29%-63.28K	23.67%270.9K	928.12%426.75K
Cash from discontinued investing activities
Operating cash flow	31.64%-1.5M	30.49%-1.81M	-34.07%-2.73M	-78.09%-9.68M	-42.52%-2.85M	-49.91%-2.19M	-117.68%-2.61M	-161.46%-2.03M	-11.62%-5.44M	42.83%-2M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities	0	74.95%-62.35K	0	6.38M	-68.16K	0	-248.93K	6.7M	0	0
Net common stock issuance	--0	--0	--0	--6.65M	--0	--0	--0	--6.65M	--0	--0
Proceeds from stock option exercised by employees	--0	--0	--0	--52.4K	--0	--0	--0	--52.4K	--0	--0
Net other financing activities	--0	----	----	---317.08K	---68.16K	--0	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	--0	74.95%-62.35K	--0	--6.38M	---68.16K	--0	---248.93K	--6.7M	--0	--0
Net cash flow
Beginning cash position	-59.37%6.64M	-55.65%8.52M	-22.69%11.25M	-27.21%14.55M	-14.40%14.16M	-9.18%16.36M	0.03%19.21M	-27.21%14.55M	560.69%19.99M	400.37%16.55M
Current changes in cash	31.64%-1.5M	34.37%-1.88M	-158.45%-2.73M	39.29%-3.3M	-45.92%-2.92M	-49.91%-2.19M	-138.44%-2.86M	699.72%4.67M	-132.06%-5.44M	-111.99%-2M
End cash Position	-63.66%5.15M	-59.37%6.64M	-55.65%8.52M	-22.69%11.25M	-22.69%11.25M	-14.40%14.16M	-9.18%16.36M	0.03%19.21M	-27.21%14.55M	-27.21%14.55M
Free cash flow	31.64%-1.5M	30.49%-1.81M	-34.07%-2.73M	-78.09%-9.68M	-42.52%-2.85M	-49.91%-2.19M	-117.68%-2.61M	-161.46%-2.03M	-11.62%-5.44M	42.83%-2M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall